Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation
- PMID: 20167280
- DOI: 10.1016/j.bbmt.2010.02.008
Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation
Abstract
There is endothelial activation and damage in hematopoietic stem cell transplantation (HSCT). The impact of the conditioning and type of HSCT on endothelial dysfunction in the early phases of HSCT has been evaluated. Plasma samples were obtained before and at different times after autologous and allogeneic HSCT with and without early complications. Changes in soluble markers of endothelial damage (VWF, ADAMTS-13, sVCAM-1, sICAM-1, and sTNFRI) were measured. There were changes in all markers evaluated that followed different patterns in auto and allo settings. For VWF and sTNRI, progressive increases from day Pre to day 14 and to day 21 were observed in the auto and the allo group, respectively. ADAMTS-13 activity correlated inversely with VWF levels. Levels of sVCAM-1 decreased until day 7, and raised significantly to day 14 and to day 21 in the auto and the allo HSCT, respectively. No significant changes were detected for sICAM-1. Our results confirm that there is endothelial damage at the early phases of HSCT, apparently induced by the consecutive effects of the conditioning, the proinflammatory agents used during transplantation, the translocation of endotoxins across the damaged gastrointestinal tract, and the engraftment. However, the comparative analysis between patients with and without complications suggests that none of these markers has diagnostic or prognostic value.
Similar articles
-
The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.Biol Blood Marrow Transplant. 2009 May;15(5):537-46. doi: 10.1016/j.bbmt.2009.01.013. Biol Blood Marrow Transplant. 2009. PMID: 19361745
-
Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.Bone Marrow Transplant. 2004 Dec;34(12):1015-23. doi: 10.1038/sj.bmt.1704733. Bone Marrow Transplant. 2004. PMID: 15516935 Review.
-
[Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].Zhonghua Xue Ye Xue Za Zhi. 2004 Jul;25(7):389-92. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 15355688 Chinese.
-
Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.Biol Blood Marrow Transplant. 2009 Nov;15(11):1376-85. doi: 10.1016/j.bbmt.2009.06.017. Epub 2009 Aug 19. Biol Blood Marrow Transplant. 2009. PMID: 19822296 Clinical Trial.
-
The role of the endothelium in the short-term complications of hematopoietic SCT.Bone Marrow Transplant. 2011 Dec;46(12):1495-502. doi: 10.1038/bmt.2011.65. Epub 2011 Apr 4. Bone Marrow Transplant. 2011. PMID: 21460864 Review.
Cited by
-
Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide.Front Immunol. 2019 Oct 9;10:2339. doi: 10.3389/fimmu.2019.02339. eCollection 2019. Front Immunol. 2019. PMID: 31649666 Free PMC article. Clinical Trial.
-
Association between genetic variants in adhesion molecules and outcomes after hematopoietic cell transplants.Int J Immunogenet. 2013 Apr;40(2):108-15. doi: 10.1111/j.1744-313X.2012.01131.x. Epub 2012 May 30. Int J Immunogenet. 2013. PMID: 22646485 Free PMC article.
-
Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects.Haematologica. 2018 Sep;103(9):1527-1534. doi: 10.3324/haematol.2017.183012. Epub 2018 Jun 7. Haematologica. 2018. PMID: 29880610 Free PMC article.
-
Differential protein expression in endothelial cells exposed to serum from patients with acute graft-vs-host disease, depending on steroid response.J Cell Mol Med. 2023 May;27(9):1227-1238. doi: 10.1111/jcmm.17712. Epub 2023 Apr 4. J Cell Mol Med. 2023. PMID: 37016544 Free PMC article.
-
Prognostic plasma biomarkers of early complications and graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.EJHaem. 2020 Jul;1(1):219-229. doi: 10.1002/jha2.26. Epub 2020 Jun 17. EJHaem. 2020. PMID: 32885223 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous